Transcriptome profiling of patient derived xenograft models established from pediatric acute myeloid leukemia patients confirm maintenance of FLT3-ITD mutation

Christina D. DrenbergDivision of Pharmaceutics, College of Pharmacy, The Ohio State University, Columbus, OH, USA; ;Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA;

Daelynn R. BuelowDivision of Pharmaceutics, College of Pharmacy, The Ohio State University, Columbus, OH, USA; ;Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA;

Stanley B. PoundsDepartment of Biostatics, St. Jude Children's Research Hospital, Memphis, TN, USA;

Yong-Dong WangDepartment of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA;

David FinkelsteinDepartment of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, USA;

Richard J. RahijaAnimal Resource Center, St. Jude Children's Research Hospital, Memphis, TN, USA;

Sheila A. ShurtleffDepartment of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA;

Jeffrey E. RubnitzDepartment of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA;

Hiroto InabaDepartment of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA;

Tanja A. GruberDepartment of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA;

Jeffery M. KlcoDepartment of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA

Sharyn D. BakerDivision of Pharmaceutics, College of Pharmacy, The Ohio State University, Columbus, OH, USA; ;Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA; Correspondence[email protected]

show all

Transcriptome profiling of patient derived xenograft models established from pediatric acute myeloid leukemia patients confirm maintenance of FLT3-ITD mutation

ICMJE Forms for Disclosure of Potential Conflicts of Interest

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Transcriptome profiling of patient derived xenograft models established from pediatric acute myeloid leukemia patients confirm maintenance of FLT3-ITD mutation

ICMJE Forms for Disclosure of Potential Conflicts of Interest

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date